What's New - JAAPA

Author Guidelines Editorial Board About Us Contact Us Advertise Subscribe Issue Archive

RSS | Login | Register

AAPA Calendar

Stay up-to-date on meetings with the AAPA Calendar

PA Job Link

The PA Job Link is provided by the American Academy of Physician Assistants and is a great asset for both job seekers and employers.

myCME Spotlight

mycme.com offers FREE CME for physician assistants and other health-care professionals on a wide variety of topics in print and video. Please visit mycme.com for this month's featured courses.

What's New?

What's new in diabetes: A1C assay emerges as a diagnostic test for diabetes

Karen A. Beer, PA-C, RD, CDE February 19, 2010

A committee of international experts recommends use of the A1C assay as the new standard diagnostic test for diabetes.

What's New in HIV/AIDS: Treatment Immune reconstitution inflammatory syndrome (IRIS) can complicate management of patients on antiretroviral therapy.

Daniel L. O’Donoghue, PA-C, PhD, Tara Gleaves, PA-C, MHS; Michelle R. Salvaggio, MD, FACP December 10, 2009

What's new in HIV AIDS treatment? Immune reconstitution inflammatory syndrome is associated with recovering immune status and can make patients susceptible to infection.

Benefits and harms of widespread PSA test use still unclear

Timothy Quigley, MPH, PA-C October 22, 2009

Despite the publication of the preliminary results of two studies and the update of two sets of guidelines, the benefits of prostate cancer screening are still controversial.

Best treatment of nonhealing and problematic wounds

Erich Fogg, PA-C, MMSc August 27, 2009

The latest wound-care modalities focus on stimulation of dermal growth and angiogenesis, new dressings, and specialized treatment centers.

A simple new blood test for allergy triggers

June 16, 2009

What's New in ... Allergy testing

Meaningful progress in colon cancer therapy options

Maura Polansky, MS, PA-C; Alicia C. Ross, MPAS, PA-C April 10, 2009

What's new in colorectal cancer treatment includes new chemotherapy options for metastatic disease and individualized therapies that increase efficiency, reduce side effects, and contain costs.